Fundraising FoxVsquared Ventures — 2024 Investments
5 investments dated 2024 · listed companies and verified rows first · show all
One Data is a data management platform that structures legacy enterprise data with metadata enrichment and governance to make it reliable for analytics, reporting, and AI applications.
AI & Machine LearningData & InfrastructureEnterprise SoftwareMunich, DE
Dr. Andreas Böhm(Founder & Managing Director)inDr. Stefan Roskos(Managing Director)in
Co-investorsMolten VenturesSalviaHV Capital
Dynelectro commercializes solid oxide electrolysis (SOEC) systems for industrial hydrogen production and energy storage, with modular platforms scaling from 250 kW to multi-megawatt capacity.
CleantechDeep TechEnergyHardware
Søren Højgaard Jensenin
Co-investorsRA CapitalThe Footprint FirmYara Growth VenturesEuropean Investment BankPSV
Kano Therapeutics develops circular single-stranded DNA (cssDNA) as a genetic payload for gene-editing and other DNA-based therapies, offering an alternative to viral vectors and double-stranded DNA.
BiotechDeep TechCambridge, US
Floris Engelhardt(Executive Officer, Director)John Vroom(Director)
BoardAnn DeWitt(Director)in
Co-investorsAmino CollectiveFifty YearsLaunchpad Venture GroupMetaplanetThe Engine VenturesZAKA VC
VÆRIDION develops electric commercial aircraft designed for regional air travel, with a focus on delivering energy-efficient, clean, and affordable aviation solutions.
CleantechHardwareMobility & TransportationMunich, DE
Co-investorsCoastCapProject A VenturesWorld Fund
.svg)
Zama provides encryption technology for onchain finance that keeps blockchain addresses public while encrypting transaction amounts and commercial references at the token level.
AI & Machine LearningCrypto & Web3CybersecurityDeep TechFintechSilicon Valley, FR
Rand Hindi(Founder)inPascal Paillier(Founder)
Co-investorsCoinListEterna CapitalHack VCLunar VenturesMetaplanetMulticoin Capital+7 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.